Cargando…

Design and development of novel non-peptide agonists at NPR-C

Detalles Bibliográficos
Autores principales:	Quinteiro, Filipa Mota, Gane, Paul, Rebstock, Anne-Sophie, Worthington, Roberta, Simone, Michela, Djordevic, Snezana, Hobbs, Adrian, Selwood, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363250/ http://dx.doi.org/10.1186/1471-2210-11-S1-P54

Ejemplares similares

Differential regulation of NPR-B/GC-B by protein kinase C and calcium
por: Abbey-Hosch, Sarah E, et al.
Publicado: (2005)

Biophysical screening methods for extracellular domain peptide receptors, application to natriuretic peptide receptor C ligands
por: Conole, Daniel, et al.
Publicado: (2018)

HIV-1 uncoating in human CD4(+) T cells: kinetic and functional analyses
por: Chen, Nan-Yu, et al.
Publicado: (2013)

Manipulating the natriuretic peptide system for the treatment of pulmonary hypertension
por: Baliga, Reshma S, et al.
Publicado: (2009)

Enhancing natriuretic peptide bioactivity prevents bleomycin-induced pulmonary fibrosis
por: Baliga, Reshma S, et al.
Publicado: (2011)

A new small molecule inhibitor of soluble guanylate cyclase
por: Mota, Filipa, et al.
Publicado: (2015)

Integrating data on the Arabidopsis NPR1/NPR3/NPR4 salicylic acid receptors; a differentiating argument
por: Kuai, Xiahezi, et al.
Publicado: (2015)

Does a selective non-peptide angiotensin II type 2 receptor agonist reduce post-infarction left ventricular remodeling?
por: Jehle, Alexander B, et al.
Publicado: (2009)

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene
por: Miura, Kohji, et al.
Publicado: (2013)

NPR3 and NPR4 are receptors for the immune signal salicylic acid in plants
por: Fu, Zheng Qing, et al.
Publicado: (2012)

Pharmacodynamic analysis of an agonistic antibody to the costimulatory receptor GITR
por: Moody, Gordon, et al.
Publicado: (2015)

Anti-plasmodial action of de-novo-designed, cationic, lysine-branched, amphipathic, helical peptides
por: Kaushik, Naveen K, et al.
Publicado: (2012)

Ablation of Neuropilin 1 from glioma-associated microglia and macrophages slows tumor progression
por: Miyauchi, Jeremy T., et al.
Publicado: (2016)

Distinct submembrane localisation compartmentalises cardiac NPR1 and NPR2 signalling to cGMP
por: Subramanian, Hariharan, et al.
Publicado: (2018)

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein
por: Jochems, Caroline, et al.
Publicado: (2013)

Effect of beta-adrenergic agonist on alveolar fluid clearance in rats
por: Qiu, H, et al.
Publicado: (2005)

Selective V1a receptor agonists in experimental septic shock
por: Traber, Daniel
Publicado: (2007)

Intratumoral immunotherapy with the TLR7/8 agonist 3M-052
por: Smirnov, DV, et al.
Publicado: (2013)

Unraveling NPR-like Family Genes in Fragaria spp. Facilitated to Identify Putative NPR1 and NPR3/4 Orthologues Participating in Strawberry-Colletotrichum fructicola Interaction
por: Bai, Yun, et al.
Publicado: (2022)

Selective regulation of autophagy by the Iml1-Npr2-Npr3 complex in the absence of nitrogen starvation
por: Wu, Xi, et al.
Publicado: (2011)

The NPR1 ortholog PhaNPR1 is required for the induction of PhaPR1 in Phalaenopsis aphrodite
por: Chen, Jen-Chih, et al.
Publicado: (2013)

Design of HR1 and HR2 synthetic peptide analogs: Characterization of their antiviral activities and their capacities to induce neutralizing antibodies
por: Mzoughi, Olfa, et al.
Publicado: (2013)

ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
por: Mangsbo, Sara M, et al.
Publicado: (2013)

Pre-clinical development of the human CD40 agonistic antibody ADC-1013
por: Norlén, Per, et al.
Publicado: (2015)

Natural toll-like receptor agonists in prophylactic vaccines for dendritic cell activation
por: Peng, Paul, et al.
Publicado: (2015)

Bioavailability of intravenous versus subcutaneous administration of the dual GC-A and GC-B designer natriuretic peptide cenderitide in healthy canines
por: Boerrigter, Guido, et al.
Publicado: (2011)

P12-14. Design of hydrophilic, helical peptides that mimic the 4E10 epitope of HIV-1 gp41
por: Lorenz, IC, et al.
Publicado: (2009)

Alcoholic liver steatosis in mice is aggravated by low-protein diet and reversed by FXR agonist
por: Lívero, Francislaine Aparecida dos Reis, et al.
Publicado: (2012)

Effect of beta-adrenergic agonist on alveolar fluid clearance in rats with acute lung injury
por: Qiu, H, et al.
Publicado: (2005)

Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
por: Jensen, Simon S, et al.
Publicado: (2013)

Implementation of the PulsePoint smartphone application for crowd-sourcing bystander resuscitation
por: Brooks, SC, et al.
Publicado: (2014)

Silencing of CrNPR1 and CrNPR3 Alters Plant Susceptibility to Periwinkle Leaf Yellowing Phytoplasma
por: Sung, Yi-Chang, et al.
Publicado: (2019)

Construction of gold-siRNA(NPR1) nanoparticles for effective and quick silencing of NPR1 in Arabidopsis thaliana
por: Lei, Wen-Xue, et al.
Publicado: (2020)

A plant RNA virus inhibits NPR1 sumoylation and subverts NPR1-mediated plant immunity
por: Liu, Jiahui, et al.
Publicado: (2023)

Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist
por: Rupp, Matthias, et al.
Publicado: (2010)

Synergistic effects of agonistic costimulatory antibodies adsorbed to amphiphilic poly(γ-glutamic acid) nanoparticles
por: Freiburghaus, Catja, et al.
Publicado: (2013)

Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models
por: Huseni, Mahrukh, et al.
Publicado: (2014)

Anti-tumor efficacy and biomarker evaluation of agonistic anti-OX40 antibodies in preclinical models
por: Huseni, Mahrukh, et al.
Publicado: (2014)

Novel synthetic RORγ agonist compounds as a potential anti-tumor therapeutic approach
por: Hu, Xiao, et al.
Publicado: (2014)

RORgamma agonists enhance survival and memory of type 17 T cells and improve anti-tumor activity
por: Hu, Xiao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g8snsth9ukbahqnsgkbtlochvh